Biohealthmatics.com The 24th annual conference TEPR 2008 will open its doors on May 19, 2008 at the Fort Lauderdale Convention Center to more than 500 speakers, close to 5,000 attendees, and approximately 200 exhibitors.
advertisement
Biohealthmatics Centers
Home
Jobs Search
Career Center
Networking Center
Company Profiles
Knowledge Center
Industry News
Web Directory
Industry Books
Featured Articles

Biohealthmatics.com....linking professionals
advertisement

Join Us

Link To Us


Healthcare IT and Biotechnology News Release
Date of Publication: Wednesday, January 11, 2006

A.D.A.M., Inc. Appoints Kevin Noland as President and CEO

A.D.A.M., Inc. today announced that its board of directors has named Kevin Noland to serve as the company's president and chief executive officer. He will succeed Robert S. Cramer, Jr.
ATLANTA -- A.D.A.M., Inc. today announced that its board of directors has named Kevin Noland to serve as the company's president and chief executive officer. He will succeed Robert S. Cramer, Jr.


Noland, 43, has been with the company for 11 years, and currently serves as president and chief operating officer. In this role, he has been responsible for driving the performance of the company through its successful transition into the healthcare market. Prior to his career at A.D.A.M., he spent more than 10 years in the software and computer industry, including positions at General Electric and Borland International. He also held general management, operations and sales positions at several successful technology startups.

"I and the A.D.A.M. board selected Kevin to become our new CEO based on his performance in leading the company to profitability, his track record in driving shareholder value and his clear vision for moving A.D.A.M. forward in the fast changing healthcare landscape," said Robert S. Cramer, Jr. A.D.A.M.'s chairman and co-founder. "Kevin brings a unique blend of sales, finance, and operational perspectives to the company. He is ideally qualified to lead us in the critical next phase of A.D.A.M.'s growth and development. We believe that under his leadership, the company will be in the optimal position to take on all of the exciting possibilities that lay ahead."

"As today's consumers become more personally invested in their healthcare decisions, the demand for trusted, authoritative health information and decision support tools will continue to increase. This trend positions A.D.A.M. for tremendous growth, especially in the new world of consumer directed healthcare," said Noland. "A.D.A.M. is a great company with unique assets and people. It's a privilege to be a part of the management team and I look forward to building on our success."

Noland will assume his new duties effective immediately. He succeeds Robert S. Cramer, Jr., a co-founder of the company, who has served as chairman and chief executive officer since 1996. Cramer will remain as chairman of A.D.A.M.'s board of directors.



Other News Items Published on the Wednesday, January 11, 2006

 

 

 

   
Copyright © 2009 Biohealthmatics.com. All Rights Reserved. Contact Us - About Us - Privacy Policy - Terms & Conditions - Resources
Can't find what you are looking for? View our Site Map

Last Updated: 24 November 2007.